BioLineRx (BLRX) Cash & Equivalents (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.93% |
| Sep 30, 2025 | -24.17% |
| Jun 30, 2025 | 15.49% |
| Mar 31, 2025 | -13.42% |
| Dec 31, 2024 | 18.11% |
| Sep 30, 2024 | 107.66% |
| Jun 30, 2024 | -28.96% |
| Mar 31, 2024 | 40.78% |
| Dec 31, 2023 | -44.93% |
| Sep 30, 2023 | -27.01% |
| Jun 30, 2023 | 16.78% |
| Mar 31, 2023 | -14.37% |
| Dec 31, 2022 | -18.50% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 13.49% |
| Mar 31, 2022 | -11.89% |
| Dec 31, 2021 | -22.82% |
| Sep 30, 2021 | -3.73% |
| Jun 30, 2021 | 8.95% |
| Mar 31, 2021 | -4.66% |
| Dec 31, 2020 | 217.75% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 4.44% |
| Mar 31, 2020 | -4.25% |
| Dec 31, 2019 | 8.43% |
| Sep 30, 2019 | -1.75% |
| Jun 30, 2019 | 13.41% |
| Mar 31, 2019 | 28.79% |
| Dec 31, 2018 | -27.62% |
| Sep 30, 2018 | -7.96% |
| Jun 30, 2018 | -34.57% |
| Mar 31, 2018 | 52.84% |
| Dec 31, 2017 | -23.87% |
| Sep 30, 2017 | -3.37% |
| Jun 30, 2017 | 215.58% |
| Mar 31, 2017 | -10.85% |
| Dec 31, 2016 | -38.49% |
| Sep 30, 2016 | 3.53% |
| Jun 30, 2016 | -15.42% |
| Mar 31, 2016 | -17.32% |
| Dec 31, 2015 | 4.21% |
| Sep 30, 2015 | -43.43% |
| Jun 30, 2015 | 16.46% |
| Mar 31, 2015 | 39.46% |
| Dec 31, 2014 | 23.11% |
| Sep 30, 2014 | -44.17% |
| Jun 30, 2014 | -8.06% |
| Mar 31, 2014 | 2.96% |
| Dec 31, 2013 | -26.73% |
| Sep 30, 2013 | -12.52% |
| Jun 30, 2013 | 8.60% |
| Mar 31, 2013 | 44.37% |